PFKFB3 and glucose metabolic process: In summary, the aim of this study was to investigate the role and potential mechanisms of a PFKFB3 small molecule inhibitor loaded in cell membrane nanovesicles in improving glucose metabolism disorders following AP by integrating systematic bioinformatics analysis and nanovesicle drug delivery technology.